Study directory

Depression studies

Compare studies and check their requirements with the research team.

Back to overview
More filters: keywords, city, remote
6115studies shown
Showing 4,813-4,824 of 6,115
Behavioral study icon
CompletedNCT02009371

A Clinical Study of Light Therapy on Depressive Episodes of Bipolarity

This summary needs review. Please check the official study record and contact the research team for details.

In Beijing
Why is this study shown?

This study includes Depression among several conditions.

Bipolarity, DepressionBehavioralFrom 18 Years to 65 Years
Countries
China
Sponsor
Peking University
Condition
Bipolarity, Depression
Drug study icon
CompletedNCT00376220

A Placebo Controlled study of Riluzole in Depression in bipolarity

This study is completed in the United States. It is testing Double-Blind Placebo Controlled Trial of Riluzole for depression in bipolarity.

In Baltimore
Why is this study shown?

This study includes Depression among several conditions.

Bipolarity, DepressionDrugA study involving a medication or substance.From 18 Years to 75 Years
Countries
United States
Sponsor
Johns Hopkins University
Condition
Bipolarity, Depression
Drug study icon
CompletedNCT00232414

Quetiapine for depression

This study is completed in the United States. It is testing quetiapine for depression.

In Cincinnati
Why is this study shown?

This study includes Depression among several conditions.

Bipolarity, DepressionDrugFrom 12 Years to 18 Years
Countries
United States
Sponsor
University of Cincinnati
Condition
Bipolarity, Depression
Drug study icon
CompletedNCT01986101

A Phase III Study of SM-13496 in people with Bipolar I Depression.

This summary needs review. Please check the official study record and contact the research team for details.

Multiple locations, including Tokyo
Why is this study shown?

This study includes Depression among several conditions.

Bipolarity, DepressionDrugFrom 18 Years to 74 Years
Countries
Japan, Lithuania, Malaysia, ...
Sponsor
Sumitomo Pharma Co., Ltd.
Condition
Bipolarity, Depression
Drug study icon
TerminatedNCT00535262

A Study Assessing EmSam in Depression in bipolarity

This summary needs review. Please check the official study record and contact the research team for details.

In New York
Why is this study shown?

This study includes Depression among several conditions.

Bipolarity, DepressionDrugFrom 18 Years to 65 Years
Countries
United States
Sponsor
New York State Psychiatric Institute
Condition
Bipolarity, Depression
Behavioral study icon
CompletedNCT06832462

A Prospective and Experimental Study on the Effect of One-Day of Acceptance and Commitment Therapy (ACT) on Psychological Flexibility, Psychological Capital, Anxiety and Depression Among Undergraduate Students.

This study is completed in Malaysia. It focuses on depression.

In Johor Bahru
Why is this study shown?

This study includes Depression among several conditions.

Anxiety, DepressionBehavioralFrom 18 Years to 29 Years
Countries
Malaysia
Sponsor
Universiti Teknologi Malaysia
Condition
Anxiety, Depression
Drug study icon
CompletedNCT00282464

Geodon for depression

This study is completed in the United States. It is testing geodon for depression.

Multiple locations, including Dothan
Why is this study shown?

This study includes Depression among several conditions.

Bipolarity, DepressionDrugOver 18 Years
Countries
United States
Sponsor
Pfizer's Upjohn has merged with Mylan to form Viatris Inc.
Condition
Bipolarity, Depression
Drug study icon
CompletedNCT00141271

Geodon for depression

This study is completed in the United States. It is testing geodon for depression.

Multiple locations, including Birmingham
Why is this study shown?

This study includes Depression among several conditions.

Bipolarity, DepressionDrugOver 18 Years
Countries
United States
Sponsor
Pfizer's Upjohn has merged with Mylan to form Viatris Inc.
Condition
Bipolarity, Depression
Drug study icon
CompletedNCT00844857

A Study for Assessing Treatment of Patients Ages 10-17 With Depression in bipolarity

This summary needs review. Please check the official study record and contact the research team for details.

Multiple locations, including San Diego
Why is this study shown?

This study includes Depression among several conditions.

Bipolarity, DepressionDrugFrom 10 Years to 17 Years
Countries
United States, Russia
Sponsor
Eli Lilly and Company
Condition
Bipolarity, Depression
Drug study icon
CompletedNCT05328297

JNJ-55308942 for depression in bipolarity

This study is completed in the United States, in Canada, in Poland, .... It is testing JNJ-55308942 for depression in bipolarity.

Multiple locations, including Huntsville
Why is this study shown?

This study includes Depression among several conditions.

Bipolarity, DepressionDrugFrom 18 Years to 64 Years
Countries
United States, Canada, Poland, ...
Sponsor
Janssen Pharmaceutica N.V., Belgium
Condition
Bipolarity, Depression
Data coverage

Public registry coverage is progressing

HopeStage gathers information about mental health clinical trials from the public registries we currently index. We are progressively improving registry coverage, but this does not mean that every study in the world is already included.